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We report here that guanylyl cyclase activity is asso-
ciated with two large integral membrane proteins
(PfGCa and PfGCb) in the human malaria parasite Plas-
modium falciparum. Unusually, the proteins appear to
be bifunctional; their amino-terminal regions have
strong similarity with P-type ATPases, and the sequence
and structure of the carboxyl-terminal regions conform
to that of G protein-dependent adenylyl cyclases, with
two sets of six transmembrane sequences, each followed
by a catalytic domain (C1 and C2). However, amino acids
that are enzymatically important and present in the C2
domain of mammalian adenylyl cyclases are located in
the C1 domain of the P. falciparum proteins and vice
versa. In addition, certain key residues in these domains
are more characteristic of guanylyl cyclases. Consistent
with this, guanylyl cyclase activity was obtained follow-
ing expression of the catalytic domains of PfGCb in
Escherichia coli. In P. falciparum, expression of both
genes was detectable in the sexual but not the asexual
blood stages of the life cycle, and PfGCa was localized to
the parasite/parasitophorous vacuole membrane region
of gametocytes. The profound structural differences
identified between mammalian and parasite guanylyl
cyclases suggest that aspects of this signaling pathway
may be mechanistically distinct.
The life cycle of the human malaria parasite Plasmodium
falciparum is complex with several stages that differ at both
the morphological and biochemical levels. Mosquito transmit-
ted sporozoites migrate to the liver where they undergo asexual
multiplication within hepatocytes. Liver forms are then re-
leased into the bloodstream where they invade red blood cells.
A small proportion of the erythrocytic forms develop into ga-
metocytes, precursors of male and female gametes. When ga-
metocytes are taken up by a mosquito during a bloodmeal, they
must first emerge from the red blood cells as gametes before
fertilization occurs in the midgut, prior to completion of the
insect stages of the parasite life cycle. The emergence of eight
motile male gametes from a red blood cell is known as exflag-
ellation. Recent work (1) has identified xanthurenic acid, a
metabolite of tryptophan, as a putative in vivo gametocyte-
activating factor. In both P. falciparum and Plasmodium
berghei there is evidence that cyclic GMP may be involved in
the development and emergence of male gametes (2). The par-
asite signaling pathways involved in these processes remain to
be elucidated.
Two key components of signal transduction pathways are
adenylyl cyclase (AC)1 and guanylyl cyclase (GC), enzymes that
catalyze the conversion of ATP and GTP to cAMP and cGMP,
respectively. Membrane-associated mammalian ACs are acti-
vated indirectly following interaction of a ligand with a sepa-
rate receptor. This in turn binds to an intracellular heterotri-
meric GTP-binding protein (G protein). Subunits of the
activated G protein then interact with AC stimulating the
synthesis of cAMP, which activates cAMP-dependent protein
kinase (PKA). PKA phosphorylates a number of proteins; its
final destination is often the nucleus where it activates tran-
scription factors, thereby changing the pattern of gene expres-
sion. In mammals, nine distinct membrane-localized ACs have
so far been characterized (3). They conform to the same basic
structure comprising two sets of six hydrophobic transmem-
brane domains, each of which is followed by a cytoplasmic
catalytic region termed C1 and C2, respectively. The amino-
terminal portions (C1a and C2a) are homologous with each
other and between species (4). Guanylyl cyclase exists in two
main forms. The receptor form (with a single membrane-span-
ning domain) binds directly to an extracellular ligand leading
to activation and production of intracellular cGMP. The solu-
ble, cytosolic form of the enzyme is activated by nitric oxide in
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the presence of heme (reviewed in Ref. 5). GCs have a variety of
roles in higher organisms, for example in photoreceptor signal
transduction (reviewed in Ref. 6). GCs have also been identified
in several lower organisms including protozoans such as Dic-
tyostelium (7), Paramecium, and Tetrahymena (8, 9). In sea
urchins, a membrane-bound GC found on the surface of sperm
can act as a receptor for peptides released by the eggs, which
influence sperm chemotaxis (reviewed in Ref. 10). cGMP often
exerts its function by binding to and activating cGMP-depend-
ent protein kinase, which phosphorylates and regulates the
activity of a number of specific proteins.
As part of an investigation of the role of cyclic nucleotides in
signal transduction in the malaria parasite, we have isolated
two genes from P. falciparum that encode integral membrane
proteins. These proteins are unusual in that they appear to be
bifunctional. The amino-terminal regions have strong similar-
ity to P-type ATPases, and the carboxyl-terminal regions, in-
cluding domains with GC activity, conform to a structure nor-
mally associated with G protein-dependent ACs.
EXPERIMENTAL PROCEDURES
Parasite Culture—P. falciparum clones 3D7A (11), T996 (12), and
strain K1 (12) were cultured in flasks with RPMI 1640 medium sup-
plemented with 25 mM Hepes, 0.1 mM hypoxanthine, 10% human serum
(A1) as described previously (13). Cultures contained A1 human red
blood cells at a 10% hematocrit. Large scale parasite preparations of
clone 3D7A were produced using a semi-automated continuous flow
apparatus. Gametocytes (stages III–V) were harvested and purified by
Percoll gradient centrifugation (13).
Isolation of Nucleic Acids—Genomic DNA was isolated from 109
mixed asexual erythrocytic stage parasites according to standard pro-
cedures (14). Briefly, the parasites were first released from red blood
cells by treatment with 0.1% saponin in phosphate-buffered saline. The
cell pellet was then washed twice with phosphate-buffered saline and
incubated in a solution containing 100 mg ml21 proteinase K, 0.5% SDS,
100 mM NaCl, 10 mM Tris, pH 8.0, 25 mM EDTA at 37 °C for 16 h. DNA
was further purified by phenol extraction and ethanol precipitation.
Total RNA was isolated from 5 3 108 gametocytes (mainly stages III–V)
or mixed asexual erythrocytic stage parasites by lysis with 4 M guani-
dine thiocyanate and CsCl centrifugation (15).
Amplification of PfGCa Sequences by PCR—A 220-bp fragment of the
PfGCa gene was isolated from genomic DNA (strain K1) by PCR using
the degenerate primers DC1 (sense) and MS2 (antisense), which were
derived from conserved regions of AC/GC genes from diverse species.
The reactions (50 ml) were carried out in 10 mM Tris, pH 8.8, 50 mM KCl,
0.5–5 mM MgCl2, and 1% Triton X-100 with 1 mM of each primer, 200 mM
dNTP mix, 1 unit of Biotaq enzyme (Bioline) and 1–50 ng of template
DNA. To minimize nonspecific amplification products, the “touchdown”
method (16) of thermal cycling was used with the following conditions:
first cycle, 94 °C (2.5 min), 41 °C (1 min), and 72 °C (1 min); and second
cycle, 94 °C (45 s), 40 °C (1 min), and 72 °C (1 min). The annealing
temperature was then decreased by 1 °C each two cycles until it reached
35 °C. 25 cycles were performed under these conditions. A final cycle
was then carried out at 94 °C (45 s), 35 °C (1 min), and 72 °C (10 min).
Inverse PCR (17) was used to extend the available PfGCa sequence
after library screening (below) failed to isolate the full-length gene.
Based on Southern blot data, an AluI digest of genomic DNA (1 mg,
strain K1) was circularized with T4 DNA ligase, and an overlapping
fragment was obtained by inverse PCR using primers IPCR1 and
IPCR2.
Construction of a Genomic DNA Library—A lGEM-12 library was
constructed with P. falciparum (strain K1) genomic DNA using a Pro-
mega kit according to the manufacturer’s instructions. Briefly, a Sau3a
partial digest of genomic DNA was end-filled and ligated with blunt-
ended XhoI cut lGEM-12 arms. After ligation, the DNA was packaged
in vitro using a Packagene Extract (Promega) and plated on Escherichia
coli strain LE392. The library (containing 2.7 3 105 clones) was
screened with the original 220-bp PCR product using standard proce-
dures (14), and a genomic clone (l1) containing part of the PfGCa gene
was isolated.
Construction and Screening of Vectorette Libraries—Vectorette li-
braries were constructed as described previously (18) using 1 mg of
genomic DNA (clone 3D7A) that had been digested with one of several
restriction enzymes. This DNA (200 ng) was ligated into blunt-ended
Vectorette DNA (Cambridge Research Biochemicals). Based on known
sequence and Southern blot information, PCR was performed using
specific primers (AC1–AC9 for PfGCa, pvec1–3 for PfGCb) and the
Vectorette I primer (Cambridge Research Biochemicals). With this pro-
cedure we were able to obtain the remainder of the PfGCa coding
sequence and the cyclase-encoding domain of PfGCb. In the PCR reac-
tions, the polymerase was added to the tubes in the cycling block when
the reaction temperature was at least 80 °C. This “hot start” and the
use of annealing temperatures in the range 60–70 °C were important
for the success of the reaction.
Oligonucleotides—The following oligonucleotides were used: DC1,
59-GTATATAAAGTAGAAAC(A/T)AT(T/A)GG; MS2, 59-(T/A)CC(A/G)A-
A(T/G)AA(A/G)CA(A/G)TA(T/A)C(T/G)(T/A)GGCAT; IPCR1, 59-TTAT-
GATCATCAATAAATAC; IPCR2, 59-TTATTATTCATATCAGC; AC1, 59-
TGTATCACCATCGATTGTATTAAATG; AC2, 59-CATAATAATTACTT-
GTATCACCATCG; AC3, 59-ACGAGTAGGTTCAATACTGGCCAC;
AC4, 59-GGAAATAAAACTGCTTGAAATACTCC; AC5, 59-GAATATGC-
TTCTGTTTAAATTCCTTTTTG; AC6, 59-TTTTGAATATGCTTCTGTT-
TAAATTCC; AC7, 59-GGCATTACTATTTTCTAAGGCAGC; AC8, 59-A-
TGAGCAAGCATCATCATACATTC; AC9, 59-TCTTCTTTGTCTTCATA-
TGCATAGG; 5CAT, 59-CGCGCGAATTCTCTACCTATTGTAAAGAAT-
CA; 3CAT, 59-CGCGCGAATTCCAAATTCGACTGGCGATCGTT;
pvec1, 59-ATCAATTCGTTTACTATATCTACTATC; pvec2, 59-TTAACA-
GATCCAATCACACCACTG; and pvec3, 59-ACGTGTGGTTGTAATGT-
AGATACC (degenerate positions are marked with slashes).
Nucleic Acid Analysis—To isolate chromosome-sized DNA, asexual
blood stage parasites were first released from red blood cells by saponin
lysis and then washed in TSE buffer (20 mM Tris, pH 8.0, 100 mM NaCl,
50 mM EDTA). The pellet was resuspended in 9 volumes of TSE and
then mixed with an equal volume of 1.6% agarose in TSE and pipetted
into a gel mold (Bio-Rad). The agarose blocks (108-109 parasites/block)
were incubated in 1% sarcosinate, 0.5 M EDTA, pH 8.0, 2 mg ml21
proteinase K for 48 h at 50 °C and then stored at 4 °C. Chromosome
separations were performed with 1% agarose gels using a contour-
clamped homogeneous field electrophoresis system (CHEF DRII, Bio-
Rad). The gels were run in 0.5% TBE buffer at 100 V for 96 h with a
pulse time of 360 s ramped to 800 s. Typically, hybridizations were
performed at 42 °C in 63 SSC and 50% formamide with washes in 13
SSC at 50 °C. For lower stringency experiments, hybridizations were at
50 °C in 53 SSC with washes in 23 SSC at room temperature. North-
ern blots were carried out using standard conditions (15).
Production of Antibodies against the C2 Catalytic Domain of
PfGCa—Oligonucleotide primers 5CAT and 3CAT were designed to
amplify the carboxyl-terminal region of PfGCa, Ser3914–Leu4226), incor-
porating the C2 catalytic domain. EcoRI restriction sites were included
in the primers to facilitate insertion of the fragment in-frame with the
Schistosoma japonicum glutathione S-transferase gene of the pGEX1lT
plasmid (Amersham Pharmacia Biotech). Expression of the fusion pro-
tein was induced in a 500-ml mid-log phase E. coli (strain JM109)
culture (A600 5 0.4–0.5) by the addition of isopropyl-1-thio-b-D-galac-
topyranoside to a final concentration of 1 mM for 2 h. Cells were
resuspended in phosphate-buffered saline /1% Triton X-100 and soni-
cated on ice. The soluble fusion protein was bound to 2 ml of glutathi-
one-agarose (Sigma) on a Poly-Prep column (Bio-Rad) according to the
manufacturer’s instructions. Bound protein was eluted by addition of 5
mM reduced glutathione and dissolved in 0.5 ml of normal saline at a
final concentration of 2 mg ml21. This was mixed with 0.5 ml of Ribi
Adjuvant System (Sigma) resuspended in 1 ml of normal saline. The
mixture was homogenized by vortexing, and a New Zealand White
rabbit was immunized at six intradermal sites (50 mg each), two intra-
muscular sites (200 mg each), and two subcutaneous sites (100 mg each).
Similar booster injections were given at 3–4-week intervals. Preim-
mune serum was taken prior to immunization.
Immunoelectron Microscopy—Percoll-purified gametocytes that had
been stimulated to undergo gametogenesis were fixed for 30 min with
2% paraformaldehyde and 0.1% glutaraldehyde in phosphate-buffered
saline, dehydrated in ethanol, embedded in LR White (London Resin
Co.), and polymerized at 50 °C for 48 h. Ultrathin sections were col-
lected on piloform-coated nickel grids and incubated with primary an-
tibody and gold-conjugated secondary antibody as described previously
(19). The sections were silver enhanced using an Amersham Pharmacia
Biotech IntenSE M silver enhancement kit and then stained with a
saturated uranyl acetate solution in 30% methanol followed by Reyn-
olds lead citrate solution. The samples were analyzed with a JEOL
1200EX transmission electron microscope at 80 kV and photographed
using Agfa Scienta EM film.
Sequence Analysis—DNA sequencing was performed using an ABI
PRISM 377 DNA sequencer. The reactions were performed with a dye
terminator cycle sequencing Ready Reaction Kit (Perkin-Elmer). Pre-
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liminary sequence data for P. falciparum chromosome 11 were obtained
from the Institute for Genomic Research website. Sequencing of chro-
mosome 11 was part of the International Malaria Genome Sequencing
Project and was supported by an award from the NIAID, National
Institutes of Health. Sequence data for P. falciparum chromosome 13
were obtained from the Sanger Center website. Sequencing of P. falcip-
arum chromosome 13 was accomplished as part of the Malaria Genome
Project with support by the Wellcome Trust.
Expression of Recombinant Proteins Corresponding to the PfGCa and
PfGCb Catalytic Domains—The cyclase catalytic domains of both
PfGCa (C1, Gly2998–Val3329, and C2, Gln3956–Lys4163) and PfGCb (C1,
Val1533–Tyr1758, and C2, Glu2946–Ala3122) and the catalytic domain of a
Trypanosoma cruzi AC (ADC-1, Arg849–Lys1169) were cloned into
pTrcHis C (Invitrogen) to give hexahistidine amino-terminal fusion
proteins. Expression of the fusion proteins in E. coli (strain TP610,
AC-deficient) was induced at 30 °C by incubation with 0.1 mM isopropyl-
1-thio-b-D-galactopyranoside for 1 h. Cultures were then lysed by son-
ication (six 10-s bursts at an amplitude of 20 mm using an MSE Soni-
prep 150) in a solution containing 50 mM NaH2PO4, pH 8.0, 300 mM
NaCl, 5 mM imidazole, 0.1% Triton X-100, 10 mM b-mercaptoethanol, 1
mM phenylmethylsulfonyl fluoride, 50 mg ml21 1-chloro-3-tosylamido-
7-amino-2-heptanone, and 1 mg ml21 lysozyme). Lysates were cleared
by centrifugation at 15,000 3 g for 20 min at 4 °C. Proteins were affinity
purified on Ni21-nitrilotriacetic acid Sepharose according to the manu-
facturer’s instructions (Qiagen).
Adenylyl/Guanylyl Cyclase Assays—AC and GC activity was assayed
in reaction volumes of 40 ml. 30-ml aliquots of fusion protein (2–5 mg)
were added to 10 ml of 43 reaction buffer (40 mM Tris, pH 8.0, contain-
ing either ATP or GTP at 4 mM and 8 mM MgCl2 or MnCl2) and
incubated at 30 °C. Reactions were stopped by addition of 10 ml of 0.2 M
EDTA, pH 8.0, followed by boiling for 2 min. For the t 5 0 time points,
EDTA was added before the protein. cAMP or cGMP concentrations
were measured in 96-well plates using a competition assay (20) with
purified regulatory subunit of beef heart cAMP-dependent protein ki-
nase as the cAMP-binding protein (PKA-R) or highly specific anti-cGMP
antibodies as the cGMP binding protein (21). Briefly, samples were
mixed with 20 ml of 0.4 mCi of [3H]cAMP (48 Ci mmol21; Amersham
Pharmacia Biotech) or [3H]cGMP (14.8 Ci mmol21) per ml of assay
buffer (4 mM EDTA in 150 mM sodium phosphate buffer, pH 7.5) and 20
ml of PKA-R or cGMP antibody preparation. After incubation on ice for
90 min, 40 ml of activated charcoal (1.25 g of charcoal and 0.5 g of bovine
serum albumin in 25 ml of assay buffer) was added to adsorb unbound
[3H]cAMP or [3H]cGMP. Samples were centrifuged at 3,000 3 g for 15
min at 4 °C. 50 ml of supernatant was mixed with 100 ml of scintillation
fluid, and the radioactivity was measured (22). A standard curve was
produced with a linear range from 0–16 pmol cAMP/cGMP.
RESULTS
Isolation of PfGCa, a Gene That Encodes a Protein with
Distinct Cyclase and ATPase Domains—Degenerate oligonu-
cleotide primers were designed based on conserved regions in
the catalytic domains of AC/GC from other species (see “Exper-
imental Procedures”). Using these, a 220-bp fragment was am-
plified by PCR from P. falciparum genomic DNA. Data base
searches suggested that the product was derived from a purine
nucleotide cyclase gene homologue. This fragment was used to
screen a genomic DNA library, and a clone was isolated. Se-
quence analysis of a 5.5-kilobase BamHI-EcoRV fragment iden-
tified a 1.8-kilobase open reading frame (ORF) corresponding to
the 39-end of a cyclase-like gene, with a putative stop codon and
adjacent 39 noncoding sequence. Inverse and Vectorette PCR
techniques (see “Experimental Procedures”) were used to ex-
tend the sequence toward the 59-end of the gene. This gener-
ated an uninterrupted ORF of approximately 10 kilobases. A
putative start codon was then identified following searches of
the Institute for Genomic Research P. falciparum data base.
Verification of the gene structure was obtained by sequencing
the corresponding region (Fig. 1), amplified from genomic DNA.
In addition the entire sequence of PfGCa has been confirmed
following release of data from the Institute for Genomic Re-
search data base, which became available during the prepara-
tion of this manuscript.
The nucleotide sequence of PfGCa comprises a single ORF of
12,678 bp (these sequence data have been submitted to the
GenBankTM data base under accession number AJ245435). The
A/T content (75.6%) and codon usage conform to that of all P.
falciparum genes reported to date. The designated termination
codon (TAA) of PfGCa occurs in a position analogous to that in
mammalian-type AC (4, 23–25) and is followed immediately by
FIG. 1. Organization of the PfGCa
and PfGCb genes. RT/PCR was used to
map introns in both genes (see “Experi-
mental Procedures”). The schematic
shows the relative positions of the introns
in PfGCb with respect to the ATPase and
cyclase domains. A schematic of the unin-
terrupted PfGCa is also shown. The sizes
of each of the 12 introns that interrupt the
PfGCb sequence and also the position
with respect to the amino acid sequence
are shown. The nucleotide sequences that
form the intron splice sites are indicated;
capital letters represent exon sequence,
and lowercase letters represent intron
sequence.
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an extremely A/T-rich region (95%). Within the ORF, two re-
gions of unusually high A/T content were identified (nucleo-
tides 7350–7530 and nucleotides 9060–9450). To investigate
the possibility of introns at these positions and elsewhere in the
gene, a series of RT/PCR reactions were carried out. There were
no differences in the sizes of the products obtained from RNA
(DNase I-treated) and genomic DNA (data not shown). In neg-
ative controls where the reaction was performed in the absence
of RT, no products were amplified. Using this approach it was
shown that PfGCa was uninterrupted by introns.
Analysis of the PfGCa sequence revealed an unexpected
finding; the gene had the potential to encode a bifunctional
protein in which the amino-terminal domain had high similar-
ity to P-type ATPases (26), and the carboxyl terminus was a
structural homologue of G protein-dependent adenylyl cycla-
ses. The nucleotide sequence adjacent to the putative start
codon is aaaaATG, which is similar to the consensus sequence
upstream of many P. falciparum genes (27). The sequence
immediately upstream of this is preceded by a highly A/T-rich
sequence interrupted by stop codons in all three reading
frames.
Isolation of PfGCb—A P. falciparum lGEM-12 library was
screened at low stringency with a probe corresponding to the
PfGCaC2 catalytic domain (see “Experimental Procedures”). A
clone containing 1.3 kilobase of sequence with similarity to
PfGCa and encompassing an in-frame stop codon was isolated.
This gene was designated PfGCb. The remainder of the cyclase
encoding region (an additional 2000 nucleotides) was obtained
from Vectorette libraries (see “Experimental Procedures”). Up-
stream, an additional open reading frame with a high degree of
similarity to P-type ATPases was discovered. The sequence of
this region was obtained from the P. falciparum genome project
(Sanger Center). The cyclase and the ATPase coding regions
were found to be separated by 241 bp of A/T-rich sequence. This
was shown to be an intron, and both coding regions were found
to form a contiguous ORF. Sequence analysis of a series of
RT/PCR products obtained using primers specific to both the
cyclase and ATPase domains demonstrated the presence of 12
introns in the PfGCb sequence. These were all confined to the
ATPase encoding domain (Fig. 1). The fully spliced transcript
has the potential to encode a bifunctional protein of 3122 amino
acids (accession number AJ249165). The 59-most exon contains
an A/T-rich sequence upstream of the designated start codon
that has stop codons in all three reading frames. Sequencing of
RT/PCR products has confirmed that this A/T-rich sequence
forms part of the mature mRNA. The predicted stop codon
(position 9367) is located upstream of a region with an ex-
tremely A/T-rich composition that has stop codons in all three
reading frames. The positions of the designated start and stop
codons are consistent with those found in other genes encoding
similar P-type ATPases and cyclases, respectively. The se-
quence of the cyclase-encoding region has been confirmed by
chromosome 13 sequence data that were released (Sanger Cen-
ter) during preparation of this manuscript. Using the
Genestream Align global alignment program the sequences of
PfGCa and PfGCb were found to share 22% identity in their
cyclase domains and 19% in their ATPase domains.
Features of the Cyclase Domains—The relatedness of both
PfGCa and PfGCb to GC/AC is concentrated in two regions
(PfGCaC1 Gly
2999–Val3329; PfCaC2, Gln
3956–Lys4163; PfGCbC1,
Val1533–Tyr1758; and PfGCbC2, Glu
2946–Ala3122), which have
26–33% sequence identity and 48–52% similarity (28) to the
corresponding regions of enzymes from diverse species. These
hydrophilic regions correspond to the positions of the catalytic
domains. PfGCaC1 is characterized by the presence of a long
asparagine-rich stretch (amino acids Asn3082–Asn3138; Fig. 2).
Interestingly, the aggregation-specific adenylyl cyclase (ACA)
of the protozoan Dictyostelium discoideum has a similar se-
quence insertion at the same position within the C1 catalytic
domain (29). There is a second, shorter insertion in PfGCaC1
(Tyr3186–Thr3225; Fig. 2) that corresponds (in terms of both
position and size) to an insert found in all of the trypanosoma-
tid ACs sequenced to date. No such inserts are present in the
cyclase catalytic domains of PfGCb. Alignment of PfGCaC1
with PfGCaC2 revealed 23% sequence identity, whereas align-
ment of PfGCbC1 and PfGCbC2 gave 34% identity.
The cyclase catalytic domains of both PfGCa and PfGCb are
each preceded by highly hydrophobic regions that in mem-
brane-associated mammalian ACs have been predicted to form
two sets of six transmembrane domains. The PfGCa and PfGCb
sequences are also compatible with this type of organization
(Fig. 3).
Features of the ATPase Domains—The putative ATPase do-
mains of both proteins conform to the P-type (or E1-E2) family
of cation transporting ATPases (30). The model for this family
of enzymes predicts 10 transmembrane domains arranged as a
set of four toward the amino terminus and a set of six near the
carboxyl terminus. The amino acid sequences of both PfGCa
and PfGCb are consistent with this type of structure (Fig. 3).
For both PfGCa and PfGCb the relatedness to P-type ATPases
from diverse species is concentrated in two regions and is
summarized below. The amino-terminal domain of PfGCa has
26–32% identity and 48–52% similarity over 250–300 amino
acids; for the carboxyl terminus the figures are 28–30% iden-
tity and 48–50% similarity. For PfGCb, the amino-terminal
domain has 23–25% identity and 43–46% similarity; for the
carboxyl terminus the figures are 21–23% identity and 46–48%
similarity. The membrane-spanning regions of the P-type
ATPase domains are more highly conserved than are those of
the cyclase domains. This might be expected given the potential
functional significance of these transmembrane regions. The
consensus phosphorylation site of P-type ATPases (DKTGTLT)
is present in PfGCa (Asp756–Thr762) but not in PfGCb. This
signature sequence is involved in formation of an aspartyl
phosphate intermediate during ATP hydrolysis (31).
Expression and Subcellular Localization—Southern analysis
of genomic DNA with a probe derived from the region of PfGCa
corresponding to the C2 domain produced a hybridization pat-
tern consistent with a single copy gene (data not shown). In
accordance with this, when P. falciparum (clones 3D7A and
T996) chromosomes separated by CHEFE and transferred to
nylon membranes were analyzed (the probe corresponded to
nucleotides 10,788–11,289), a single band identified as chro-
mosome 11 was detected (Fig. 4). PfGCb was localized to chro-
mosome 13. When northern blots of RNA derived from sexual
and asexual blood stage parasites were probed with PfGCa, a
transcript of approximately 12,000–14,000 nucleotides was de-
tected that was specific to the sexual blood stages (Fig. 4). The
sexual stage RNA had been prepared from Percoll-purified
gametocytes (mainly stages III–V), and the asexual stage RNA
was prepared from an asynchronous culture containing ring,
trophozoite, and schizont stages. The same blot was hybridized
with a probe derived from the ATPase-encoding domain of
PfGCa (nucleic acids 5,901–6,630), and a band of equal size
was detected (Fig. 4). A northern blot was also hybridized with
a probe corresponding to the cyclase region of PfGCb, and a
slightly smaller transcript was identified (Fig. 4). The northern
blots were hybridized with other probes (data not shown) to
demonstrate both the integrity of the RNA preparations and
the equivalence of loading as described previously (32, 33). The
probes were derived from genes encoding sexual (Pfs16) and
asexual blood stage specific proteins (Msp1) and another (cal-
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modulin) expressed in similar amounts in both stages.
A rabbit polyclonal antiserum was raised to a recombinant
protein corresponding to the carboxyl terminus of PfGCa (ami-
no acids Ser3914–Leu4226, incorporating the C2 catalytic do-
main) fused to glutathione S-transferase (see “Experimental
Procedures”). The serum was used in immunoelectron micro-
scopic examination of sections of red blood cells infected with P.
falciparum. Antibody binding was visualized by using a colloi-
dal gold-conjugated secondary antibody. Sexual erythrocytic
stage parasites (gametocytes) were strongly labeled in the plas-
ma/parasitophorous vacuole membrane region of the parasite
(Fig. 5). Only very low levels of gold particles were observed in
the gametocyte cytoplasm. Little or no labeling was present on
uninfected red blood cells or asexual blood stage parasites (Fig.
5). These sections also contained a small proportion of devel-
oping gametes at various stages of emergence from the sur-
rounding red blood cell membrane and parasitophorous vacuole
membrane. No gold particles were observed in these forms.
Preimmune serum from the rabbit showed little or no labeling
at the same concentration as the test serum. An antiserum
raised to a control glutathione S-transferase fusion protein
(derived from Schistosoma mansoni) also gave no significant
labeling.
Guanylyl Cyclase and Adenylyl Cyclase Enzyme Assays—The
regions of PfGCa encoding both the C1 (Gly2999–Val3329) and
C2 (Gln3956–Lys4163) domains and the regions of PfGCb encod-
ing both C1 (Val1533–Tyr1758) and C2 (Glu2946–Ala3122) were
expressed in E. coli strain TP610 (AC-deficient) using an ami-
no-terminal hexahistidine tag system. The selection of these
regions was based on the scheme used for expression/crystalli-
zation of the rat type II AC C2 domain (25). Coomassie Blue-
stained SDS-polyacrylamide gels and Western blots (using a
monoclonal antibody that reacts with a vector-derived epitope
at the amino terminus of fusion protein) showed distinct bands
at the predicted molecular masses (47 kDa for PfGCaC1, 32 kDa
for PfGCaC2, 34 kDa for PfGCbC1, and 28 kDa for PfGCbC2) of
the fusion proteins (data not shown). The fusion proteins, pu-
rified by affinity chromatography on Ni21-nitrilotriacetic acid
Sepharose columns, were tested for AC or GC activities. Levels
of cAMP/cGMP were measured by a competition assay using
3H-labeled cAMP or cGMP (see “Experimental Procedures”).
The purified fusion proteins were first assayed for AC activ-
FIG. 2. Sequence alignment. Alignment of the catalytic domains of PfGCa and PfGCb with those of the mammalian soluble guanylyl cyclases
GCa1 and GCb1 (49), the C1 domains of both mammalian type V adenylyl cyclase (VC1, (50)) the Dictyostelium ACA (29), and the C2 domain of
rat type II adenylyl cyclase (IIC2). The known secondary structure of the mammalian type V C1 domain (from a crystallographic study (36)) is
indicated by thick lines (a helix) and arrows (b sheet) beneath the sequence. The alignment illustrates the reversal of the C1 and C2 domains of
the Plasmodium proteins in terms of key functional residues compared with the C1 and C2 domains of mammalian adenylyl cyclases. The residues
that determine purine binding specificity are marked with a plus symbol; green residues are indicative of adenine binding, and red residues are
indicative of guanine binding. Other functionally important residues, determined by mutagenesis and structural studies (discussed in the text) are
indicated and have been shown as follows. Light blue r, ribose binding; light blue p, phosphate binding; dark blue m, divalent cation binding. The
amino acid residue numbers of each sequence are given on the right. The alignment was produced using the PILEUP program in the GCG package
(51).
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ity. No AC activity was obtained using the aC1, aC2, bC1, or
bC2 proteins derived from these constructs either separately or
in combination (Fig. 6). The catalytic domain of a receptor-type
AC (ADC-1) from T. cruzi was purified and assayed in parallel.
This fusion protein gave a high level of AC activity which was
maximized in the presence of Mn21 ions (34). We were also able
to demonstrate functional complementation of the AC-deficient
E. coli strain (TP610) with the trypanosome-derived construct,
FIG. 3. A model of the proposed structure of PfGCa and PfGCb. The deduced amino acid sequences are each consistent with the presence
of two sets of six transmembrane regions in the cyclase domain and two further sets of four and six transmembrane regions in the ATPase domain.
The cytoplasmic domains of the ATPase are based on a model proposed for a muscle Ca21-ATPase (31, 52).
FIG. 4. Chromosomal location and
expression. A, autoradiograph of a
northern blot containing 10 mg of total
RNA from P. falciparum (clone 3D7A)
erythrocytic asexual (A) and sexual stage
(S) parasites. The four panels from left to
right correspond to the respective probes:
PfGCa (C2 domain), PfGCa (ATPase do-
main), PfGCb (C2 domain), and msp1 (a
gene expressed specifically in asexual
blood stage parasites). The size of the
PfGCa gene transcript is indicated.
Ethidium staining of agarose gels was
used to verify equivalent loading of tracks
and integrity of the RNA. B, CHEFE sep-
aration of chromosomes from P. falcipa-
rum clones T996 (lanes 1, 3, and 5) and
3D7A (lanes 2, 4, and 6). Electrophoresis
conditions were as described in “Experi-
mental Procedures.” Lanes 1 and 2 show
an ethidium bromide-stained agarose gel.
After transfer to a nylon membrane the
DNA was hybridized with PfGCa (lanes 3
and 4) or RESA-2 (lanes 5 and 6). RESA-2
has been localized previously to chromo-
some 11 (53). Similar results were ob-
tained with the P. falciparum K1 strain-
(data not shown).
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but this was not achievable with the Plasmodium-derived con-
structs (data not shown).
We then tested the fusion proteins for GC activity. Fig. 7A
shows that the C1 and C2 domains from the PfGCa gene
showed no significant activity over isolates from control bacte-
ria either when tested individually or in combination with each
other. However, the fusion proteins derived from the PfGCb
gene showed moderate levels of activity when tested individu-
ally, with bC1 being somewhat more active than bC2. When
used in combination, however, considerably elevated levels of
activity were obtained (Fig. 7B). Following a brief lag period,
cGMP synthesis increased rapidly over the first 10 min before
decreasing. To test whether the transient nature of this activity
was due to the low stability of the enzyme, we incubated the
C1/C2 mixture at 30 °C for 25 min prior to the assay; this
resulted in complete loss of activity (Fig. 7C). Addition of fors-
kolin, Ca21, or Ca21/calmodulin to the reaction mixtures did
not affect the level of GC activity (data not shown). In all cases
activity was dependent on the presence of Mn21 ions. If the
divalent cation was replaced with Mg21, no activity could be
detected. Proteins from bacteria transformed with control
pTrcHis plasmid showed no activity.
DISCUSSION
We have isolated two genes from P. falciparum that encode
proteins with cyclase-like domains similar in structure to the
membrane-localized adenylyl cyclases of higher eukaryotes.
Unusually, the catalytic regions of at least one of these en-
zymes has guanylyl cyclase activity. During the preparation of
this manuscript, a GC with this type of structure was also
described in Paramecium (9). An additional remarkable feature
found in both the Plasmodium and Paramecium proteins is
that they each have an amino-terminal domain with high sim-
ilarity to P-type ATPases in terms of sequence and predicted
structure. GCs have hitherto fallen into two subclasses: (i)
membrane-associated receptor molecules that form ho-
modimers each with a single transmembrane domain and (ii)
soluble molecules that form heterodimers. PfGCa and PfGCb
therefore fall into a third subclass that is membrane-associated
(with 12 putative membrane-spanning domains) with a pair of
catalytic domains. As in mammalian ACs, their activity is
probably mediated by interaction of the C1 and C2 domains.
Northern analysis of mRNA from the erythrocytic stages of
P. falciparum also indicated that expression of both genes is
restricted to gametocytes (Fig. 4). Immunoelectron microscopy
localized PfGCa to the plasma/parasitophorous vacuole mem-
brane region of this stage of the life cycle (Fig. 5). In red blood
cells, malaria parasites are surrounded by three membranes:
the host cell membrane, the parasitophorous vacuole mem-
brane, and the parasite plasma membrane. The latter two
membranes are closely opposed, and it is not clear from our
electronmicrographs in which membrane PfGCa is located (Fig.
5). However, it can be inferred from the sequence and by
comparison with other cyclases that both PfGCa and PfGCb
are integral membrane proteins. The parasites used for the
immunoelectron microscopy study had been stimulated to un-
dergo gametogenesis (see “Experimental Procedures”). The mi-
crographs show parasites at various stages of emergence from
the red blood cell and parasitophorous vacuole membranes. No
labeling is associated with extracellular gametes, suggesting
that PfGCa has a pre-emergence role.
Structural Comparison of the PfGCa and PfGCb Catalytic
Domains with Those of Mammalian Adenylyl Cyclases—The
active site of mammalian AC is formed by the interaction of the
C1 and C2 domains (35). Recent crystallographic and mutagen-
esis studies have given insight into the nature of the catalytic
site and have identified residues involved in ATP binding (3,
25, 36–38). Based on these studies, models for the analogous
binding of GTP within the active site of GC have been derived.
From sequence alignment, it can be inferred that the cyclase
catalytic domains of both PfGCa and PfGCb are different from
those of mammalian G protein-dependent ACs in that the C1
and C2 domains appear to be structurally reversed. Several
catalytically important residues that are present in the mam-
malian C2 domain are found only in the C1 domain of the
Plasmodium molecules (Fig. 2). Likewise, mechanistically im-
portant residues present in the C1 domain of the mammalian
enzyme are located in the C2 domains of PfGCa and PfGCb.
For example, in mammalian AC it has been predicted that
Arg398 (type I AC), which approaches the b phosphate of ATP,
and Arg1011, which interacts with the a phosphate, are local-
ized in the C1 and C2 domains, respectively (36, 39). The
equivalent residues in PfGCa (Arg4070 and Arg3268) and PfGCb
(Arg3063 and Arg1696) are reversed with respect to their location
FIG. 5. Subcellular localization of PfGCa. Sections of P. falcipa-
rum (clone 3D7A) erythrocytic stages were incubated with an anti-
PfGCa polyclonal antibody (1:3000 dilution, “Experimental Proce-
dures”), and binding was visualized using a gold-conjugated secondary
antibody. Upper panel, gold particles indicative of antibody binding are
associated with the periphery of the gametocyte encapsulated in a red
blood cell. Only very low numbers of gold particles can be detected in the
cytoplasm. Middle panel, a transverse section of a gametocyte showing
similar labeling. Lower panel, little or no binding of the antibody is
detectable with asexual erythrocytic stage parasites. This section shows
a schizont with levels of gold particles similar to that obtained in all
sections with preimmune serum (data not shown). Size bars have been
inserted in each panel.
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(Fig. 2). Similarly, three residues in mammalian AC that in-
teract with the ribose moiety of ATP, Thr315 (type I C1), Asp354
(type I C1), and Asn1007 (type I C2), are localized in the opposite
catalytic domain in the Plasmodium enzymes (Fig. 2). The
equivalent positions in PfGCa are Thr3973 (C2), Asp4019 (C2),
and Asn3264 (C1), and in PfGCb they are Thr2973 (C2), Asp3012
(C2), and Asn1692 (C1). In type I mammalian AC, three nega-
tively charged residues (Asp354, Asp310, and Glu432) localized in
the C1 domain are thought to be involved in Mg21 binding, an
essential requirement for enzyme activity (Refs. 3 and 39 and
Fig. 2). The corresponding negatively charged residues in
PfGCa (Asp4019, Asp3975, and Glu4104) and PfGCb (Asp3012,
Asp2968, and Glu3097) are all in the C2 domain.
Purine Binding Specificity—The highly conserved regions of
mammalian-type ACs (C1a and C2a) are very similar to the
corresponding regions of the catalytic domains of GCs. Mu-
tagenesis and crystallographic studies have shown that a small
number of residues are involved in conferring the purine bind-
ing specificity of the two enzymes (36, 37, 39, 40). Two separate
studies have demonstrated that the purine specificity of GC
can be altered by changing key residues to their counterparts
in AC (E925K and C997D of retinal guanylyl cyclase 1, retGC-1
(39); R592Q of soluble GCa1; E473K and C541D of soluble
GCb1 (37)). This results in conversion to an enzyme with an AC
activity. These studies indicate a direct interaction between
Glu925 of GC and the N1 and N2 positions of the guanine ring.
In the C1 catalytic domains of both PfGCa and PfGCb, the
corresponding position is occupied by a glutamic acid residue
(Glu3058 and Glu1591, respectively) as would be expected in a
GC, and not lysine as in AC. However, the Plasmodium en-
zymes are distinct from their mammalian counterparts in that
residues in the PfGCa and PfGCb positions that correspond to
the Cys997 (retGC-1), thought to be important for guanine
binding specificity, are both alanines (Ala3257 and Ala1785, re-
spectively; Fig. 2). In the Paramecium GC, the corresponding
position is occupied by a serine (9). It has been proposed (36)
that the glutamic acid residue (Glu473, GCb) is probably the
most important residue for determining GTP binding specific-
FIG. 6. Adenylyl cyclase enzyme activity assays. The graphs show time courses of cAMP production by the recombinant catalytic domains
derived from T. cruzi ADC-1 and PfGCa and PfGCb. The data represent the means 6 S.E. of three independent experiments. 2–5 mg of affinity
purified His6-tagged fusion proteins were incubated at 30 °C for the indicated time periods with 2 mM ATP and 4 mM Mn
21 and assayed for cAMP
as described under “Experimental Procedures.” Control assays were performed on proteins purified from cultures containing plasmid (pTrcHisC,
Invitrogen) with no insert. A, the catalytic domains of PfGCa (aC1 and aC2) were assayed both separately and in combination (aC1/aC2). B, the
catalytic domains of PfGCb (bC1 and bC2) were assayed separately and in combination (bC1/bC2). C, the catalytic domain of ADC-1 derived from
T. cruzi (34) was cloned into pTrcHisC, purified, assayed in parallel, and used as an AC positive control.
FIG. 7. Guanylyl cyclase enzyme activity assays. The graphs show time courses of cGMP production by the recombinant catalytic domains
derived from PfGCa and PfGCb. The data represent the means 6 S.E. of three independent experiments. 2–5 mg of affinity purified His6-tagged
fusion proteins were incubated at 30 °C for the indicated time periods with 2 mM GTP and 4 mM Mn21 and assayed for cGMP as described under
“Experimental Procedures.” Control assays were performed on proteins purified from cultures containing plasmid (pTrcHisC, Invitrogen) with no
insert. A, the catalytic domains of PfGCa (aC1 and aC2) were assayed both separately and in combination (aC1/aC2). B, the catalytic domains of
PfGCb (bC1 and bC2) were assayed separately and in combination (bC1/bC2). C, a further time course experiment showing the effect of
preincubation of bC1/bC2 at 30 °C for 25 min.
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ity. This was inferred from studies in which mutated cyclases
lacking a glutamic acid at this position were shown to have no
GC activity. Modelling studies (36, 37, 39) have also indicated
that an arginine residue (Arg539, GCb, and Arg592, GCa) is
important for GTP binding. The arginine residue at this posi-
tion is conserved in GCs, and the corresponding positions in the
C2 domains of both PfGCa and PfGCb are also occupied by
arginines (Arg4089 and Arg3082, respectively).
Enzyme Activity of PfGCa and PfGCb—Recombinant pro-
teins expressed in E. coli corresponding to the C1 and C2
catalytic domains of PfGCa and PfGCb were tested for both AC
and GC activity. No AC activity was detectable in any of the
four malaria-derived recombinant proteins. We were, however,
able to demonstrate GC activity in the C1 and C2 domains of
PfGCb both separately and in combination. The PfGCb C1/C2
mixture showed the highest level of cGMP synthesis. No GC
activity was detectable in the C1 or C2 domains of PfGCa
either separately or in combination. It is not clear why activity
was undetectable with PfGCa, but it is possible that in the case
of the C1 domain, the asparagine-rich insert that interrupts
the domain may interfere with catalysis in the context of this
construct. When the respective C1 and C2 domains of the
PfGCa and PfGCb were mixed with their heterologous partner
(aC1/bC2 and bC1/aC2), there was evidence of some inhibition
of activity of the PfGCb domains (data not shown). A similar
phenomenon of inhibition between two ACs from Leishmania
donovani has been reported (41). In this case activity could also
be detected in only one of the cyclases.
In the present study, we have demonstrated that although
the C1 and C2 domains of PfGCb synergize to synthesize
cGMP, the individual domains also display activity (Fig. 7).
Basal levels of AC activity have been reported in both the C1
and C2 catalytic domains of mammalian AC in the absence of
specific activators (35). By analogy, the GC activity that we
have demonstrated in this study probably represents only ba-
sal activity, because no activator has yet been identified. It is
also possible that other parts of the PfGCa and PfGCb proteins,
not included in the expressed fusion proteins, may have a
regulatory role and could be required for optimal activity.
The Association of Ca21 and Guanylyl Cyclase Activity—Of
the P-type ATPases, it is the Ca21 pump isoforms that have the
highest similarity with the amino-terminal domains of PfGCa
and PfGCb. This suggests the possibility that Ca21 may be
involved in the regulation of GC activity in P. falciparum.
Ca21-dependent GC activity has been demonstrated in a num-
ber of systems. For example, in Paramecium there is a causal
association between Ca21 influx and an increase in intracellu-
lar cGMP levels (reviewed in Ref. 42). This Ca21-dependent
cGMP production is vital to the control of ciliary movement and
locomotion. In mammals, retinal GC activity, involved in light
activation of photoreceptors, is closely associated with Ca21
levels, and it has been shown that specific calcium-binding
proteins regulate this activity (Ref. 43; reviewed in Ref. 6). The
intimate association of GC activity with a putative Ca21 pump
in PfGCa and PfGCb is intriguing in light of some earlier work
on Plasmodium (2). This has implicated both Ca21 and cGMP
in the control of exflagellation. Ca21 antagonists (but not Ca21
channel inhibitors) strongly inhibit exflagellation, whereas it is
enhanced by cGMP and agents that increase levels of cGMP. It
will therefore be of considerable interest to investigate whether
the linkage of GC activity with a putative Ca21 pump ATPase
in a single polypeptide is of functional significance.
Evolutionary Significance—It can be presumed that the
“progenitor PfGC” protein arose from the fusion of two genes,
one encoding a P-type ATPase and the second encoding a cy-
clase. This is not without precedence. There are at least two
other examples in Plasmodium of bifunctional proteins that
occur as distinct molecules in other organisms. These are the
dihydrofolate reductase-thymidylate synthase (44, 45) and di-
hydropteroate synthetase/pyrophosphokinase (46, 47). The
most likely scenario is that the initial fusion event was followed
by gene duplication creating two copies that diverged to become
PfGCa and PfGCb. The fusion event appears to have occurred
in a common ancestor of Plasmodium and Paramecium. This is
consistent with classification of the ciliates with apicomplexans
and dinoflagellates in the Alveolata (9, 48).
An additional feature of the two Plasmodium genes is the
presence of 12 introns in the ATPase encoding domain of
PfGCb, compared with none in the corresponding region of
PfGCa (Fig. 1). From a functional viewpoint, it is not immedi-
ately obvious why PfGCa and PfGCb, two proteins with the
same potential activity, should be expressed during the sexual
stages of the life cycle. One possibility is that they are ex-
pressed differentially during this complex life cycle phase. An-
other is that they are co-expressed but that they respond to
different activators. A greater understanding of this signaling
pathway and the manner in which it is regulated is of impor-
tance, particularly in the context of novel chemotherapeutic
targets. The structural differences that we have identified be-
tween Plasmodium GC and its mammalian counterparts may
be exploitable for the development of drugs capable of blocking
transmission of malaria. The recent development of genetic
manipulation techniques applicable to malaria parasites will
allow this possibility to be explored further.
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